Therapy with an emphysema drug, and transplant of pig cells could end a global epidemic, says Ben-Gurion University researcher.
Assistant Managing Editor
When Andy David’s nine-year-old daughter was diagnosed with Type 1 diabetes, the Israeli diplomat used his medical background to search for an unconventional treatment that would spare her from daily doses of insulin.
David, who is currently Israel’s consul general for the Pacific Northwest United States, soon learned about groundbreaking work at Ben-Gurion University in the Negev that shows great promise for kids in the early stages of Type 1 diagnosis.
The child (he prefers not to name her for security reasons) underwent eight weeks of transfusions of Alpha 1 Antitrypsin, an anti-inflammatory drug generally used to treat emphysema.
Not only did Mandy Patinkin make a living playing a hot-shot surgeon on the CBS series “Chicago Hope” in the ‘90s, but he’s been blessed by medical science in real life.
Between 1978 and 1998, when he was stricken with an eye disease called keratoconus and feared he was going blind, doctors saved his eyesight with corneal transplants. “I have two eyes that were given to me by two children, a 13-year-old boy and a 14-year-old girl,” he said.
WASHINGTON (JTA) -- John Hagee Ministries will discontinue funding for an Israeli right-wing group that has depicted the New Israel Fund and its affiliates as anti-Israel.
The decision to end funding for Im Tirtzu was revealed in an email by Lee Wunsch, the president of the Houston Jewish Federation, and obtained over the weekend by Richard Silverstein, a blogger who has campaigned against funding the group.
Israeli scientists in universities across the country have been forging ahead in recent months with new innovations in medicine and technology that could lead to breakthroughs.
Professor Shimon Efrat of Tel Aviv University’s Sackler Faculty of Medicine, along with graduate students Holger Russ and Yael Bar, have developed a way to cultivate healthy human beta cells in the laboratory and implant them into diabetes patients. They are now working to convince the body to accept these cells — a move that could pave the way to a new and simpler form of diabetes treatment.